Published in TB and Outbreaks Week, August 3rd, 2004
While acknowledging the current debate on the use of generic vs. branded drugs, conference participants argued that such controversies must not be used as an excuse for further delays.
"Further delay in access to HIV treatment is measured in lives," said Dr. Joep Lange, conference co-chair and president of the International AIDS Society. "While the task of scaling up access to treatment is formidable, it is within our reach if political...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.